Navigation Links
own in Medical Technology

Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit

Arizona Heart Institute Pioneers Research That May Offer New Hope to Heart Failure Patients PHOENIX, Oct. 8 /PRNewswire/ -- Nationally, over 3,000 people are waiting for a heart transplant - and a new lease on life. Sadly, only half of those will receive a transplant. Now, pioneering researc...

Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders

CHICAGO, Aug. 13 /PRNewswire-FirstCall/ -- As biotechnology, pharmaceutical and medical device companies increasingly move clinical trials beyond their own borders to other parts of the world, such as Asia, Eastern Europe and South America, complicated regulatory environments challenge those f...

Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation

Case is first to show safety and effectiveness of using cloned cells alone to kill tumors SEATTLE, June 18 /PRNewswire/ -- Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced soli...

Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells

Appoints U.S. Biotest to Oversee Trials PRINCETON, N.J., Jan. 24 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has signed a clinical services agreement with San Luis Obispo-based, p...

Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue

MINNEAPOLIS, Jan. 8 /PRNewswire/ -- Patients with knee cartilage injuries now have the opportunity to re-grow their cartilage as part of an innovative study at TRIA Orthopaedic Center, in Bloomington, MN. Cartilage is the tough but flexible tissue that covers the ends of your bones at a joint ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...m's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com . This press release contains forward-looking statements, which reflect the Compa...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...ave enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecule...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

...tch treatments. About Schering-Plough Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

Is Your Hair Taking a Break?

...r loss women experience and the current treatment options. "Hair loss is a very misunderstood condition, both in terms of how people see their own hair loss and how physicians who are not dermatologists approach hair loss," said Dr. McMichael. "It is important for women to be evaluated by a derma...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

...he possible benefits. From that point on, HRT was prescribed more conservatively with lower dosing options and individualization based on each woman's own health history. Since there were reports of some women on HRT noticing an improvement in their skin, studies were conducted to determine if the...

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

...nt-specific cancer vaccines derived from patients' own cancer cells and immune cells were well tolerated ...jected with a vaccine that included each patient's own immune cells (dendritic cells) and 500 micrograms ...ood and mixed with a cell culture of the patient's own melanoma cells that had been self-renewing and pro...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- t...

World's First Cardiac Adult Stem Cell Patient Receives Infusion

...on procedure, Jones was directly injected with his own cardiac stem cells into heart scar tissue using a ...ac stem cells were retrieved from a portion of his own atrium, the upper chamber of the heart. The tissue...al trial. We hope to help the heart regenerate its own tissue and improve heart function." Bolli is colla...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- t...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...COPD is currently in Phase III development. Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...mmune diseases, elevated levels of BLyS are believed to contribute to the production of autoantibodies - antibodies that attack and destroy the body's own healthy tissues. The presence of autoantibodies appears to correlate with disease severity. Preclinical and clinical studies suggest that belimumab ca...

Reliv International's GlucAffect(TM) Proven Effective in Clinical Study

...e people in the GlucAffect group achieved statistically significant lower blood sugar levels as well as significant weight loss compared to both their own baseline starting point and to the results of the people in the placebo group," said Dr. Carl Hastings, Reliv's vice chairman and chief scientific off...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

...d.(8) About Schering-Plough Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

...am for cancer, the unique mechanism of action of Multikine (published in the Journal of Clinical Oncology) and the way Multikine imparts the patient's own immune response with the ability to mount a robust anti-tumor immune response against his/her tumor. Dr. Talor will also discuss the clinical finding...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

...df About Schering-Plough Corporation Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures

... is using a revolutionary technology that allows patients to rebuild their own cardiovascular tissue. (Logo: http://www.newscom.com/cgi-bin/prnh/2... to repair damaged heart tissue. Over time, it is replaced by the patients' own tissue. "The use of this biomaterial is a major advancement in cardia...

June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates

...ol compresses, hydrocortisone cream and anti-inflammatory medications (Advil, Motrin, others) can help relieve symptoms. PMLE usually clears up on its own in seven to 10 days. When symptoms don't improve, patients should check with a doctor to consider other conditions or possible allergies. Poiso...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

...d thereby restore normal neuronal function." Underwood says Quincy's own study confirmed that cognitive function could be improved by lowering neuro...me overloaded with calcium. "Humans are born able to manufacture their own calcium-binding proteins but we gradually stop producing them at about age ...

Number of Patients With Dementia on the Rise

...y family history," Sabin says. "I felt studies I was participating in would help other people so that they won't have to go through what I did with my own relatives." For more information, please visit: Michigan Alzheimer's Disease Research Center (MADRC) http://www.med.umich.edu/alzheime...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

...nts or developments.) About Schering-Plough Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

ADHD Genes Found; Known to Play Roles in Neurodevelopment

...ers learn more about specific genes in neurological conditions, the hope is that researchers might in the future personalize treatments to a patient's own genetic profile, to achieve more targeted, specific therapies. Elia and White stressed that much further work must be done before genetic finding...

EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health

... on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products. Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, found...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

...ically active donor cells to support the patient's own skin cells' healing ability. HP802-247 utilizes a... can support healing of the wound by the patient's own cells. Typically caused by impaired microc...factors are anticipated to stimulate the patient's own cells to heal the wound. About HEALTHPOINT, ...

MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - t...

When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research

...alance (either increase or decrease) levels of its own hormones. Passing stringent pharmacology, toxicolo...menessence is as safe and side effect-free as your own hormones have been throughout your life. Howe...world that is vertically integrated, NHI grows its own herbs and maintains complete control over the manu...

FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- t...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

...About Schering-Plough Schering-Plough (headquartered in the US) is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

...bout Schering-Plough Schering-Plough (headquartered in the US) is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- t...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

...a via cellular networks or Bluetooth to their healthcare providers. VivoMetrics' new LifeShirt will nearly eliminate patient involvement in their own vital sign monitoring, requiring the user to simply wear the garment. Numerous studies confirm the potential of RPM initiatives to improve outcom...

Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -...

Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes

...en corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - th...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

...mprove blood sugar control by directly targeting insulin resistance, an underlying cause of type 2 diabetes. This helps the body respond better to its own natural insulin. Avandia is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus. ...
Other Tags
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 Invictus ... a prestigious Illinois university for a second innovative ... (NICUs) more conducive to newborn infants’ cognitive development. ... three NICU problems we have identified through extensive ... professionals,” said George Hutchinson, Invictus Medical’s Chief Technology ...
(Date:4/20/2015)... When author Faith Canter was diagnosed with ... could wake her up - and she wasn’t alone. The ... living with CFS. , Rather than accepting her fate, Canter ... Life Less Toxic : The Whole Life Approach to Detoxifying ... Life for You, Your Family and Our Planet.” (published by ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Using Quality ... CMOs Speed Production and Improve Compliance , **FDAnews Webinar**, ... EDT, http://www.fdanews.com/qualitybydesign , The life sciences industries ... them to do more with less. Mergers, acquisitions, ... CMOs to finds ways to speed up production while ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 The ... Susan Binau, Founder of Soul Care Group, Inc., ... Binau is recognized with this prestigious distinction for leadership ... 200 Local Chapters, NAPW is the nation's leading networking ... honor Susan with our Woman of the Year Award,” ...
(Date:4/20/2015)... The partners of Urgent Care of Westchester ... Diosa Laser Med Spa with a special event. Residents of ... from 12–7 p.m. on April 24 on 909 Midland Ave. ... refreshments. Participants will also get the chance to win free ... with any purchase, as well as up to 40 percent ...
Breaking Medicine News(10 mins):Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2
Other Contents